Literature DB >> 10397739

Detection of t(4;14)(p16.3;q32) chromosomal translocation in multiple myeloma by double-color fluorescent in situ hybridization.

P Finelli1, S Fabris, S Zagano, L Baldini, D Intini, L Nobili, L Lombardi, A T Maiolo, A Neri.   

Abstract

Chromosomal translocations involving the immunoglobulin heavy chain (IGH) locus at chromosome 14q32 represent a common mechanism of oncogene activation in lymphoid malignancies. In multiple myeloma (MM), variable chromosome partners have been identified by conventional cytogenetics, including the 11q13, 8q24, 18q21, and 6p21 loci. We and others have recently reported a novel, karyotypically undetectable chromosomal translocation t(4;14)(p16. 3;q32) in MM-derived cell lines, as well as in primary tumors. The 4p16.3 breakpoints are relatively scattered and located less than 100 kb centromeric of the fibroblast growth factor receptor 3 (FGFR3) gene or within the recently identified WHSC1 gene, both of which are apparently deregulated by the translocation. To assess the frequency of the t(4;14)(p16.3;q32) translocation in MM, we performed a double-color fluorescent in situ hybridization (FISH) analysis of interphase nuclei with differently labeled probes specific for the IGH locus (a pool of plasmid clones specific for the IGH constant regions) or 4p16.3 (yeast artificial chromosome (YAC) 764-H1 spanning the region involved in breakpoints). Thirty MM patients, the MM-derived cell lines KMS-11 and OPM2, and six normal controls were examined. The identification of a t(4;14) translocation, evaluated as the presence of a der(14) chromosome, was based on the colocalization of signals specific for the two probes; a cutoff value of 15% (mean + 3 standard deviation [SD]) derived from the interphase FISH of the normal controls (range, 5% to 11%; mean +/- SD, 8.16 +/- 2.2) was used for the quantification analysis. In interphase FISH, five patients (one in clinical stage I, two in stage II, one in stage III, and a plasma cell leukemia) were found to be positive (approximately 15%). FISH metaphases with split or colocalized signals were detected in only two of the translocated cases and confirmed the pattern found in the interphase nuclei. Furthermore, in three of the five cases with the translocation, FISH analysis with the IGH joining probe (JH) showed the presence of the reciprocal product of the translocation [der(4) chromosome]. Overall, our study indicates that the t(4;14)(p16. 3;q32) chromosomal translocation is a recurrent event in MM tumors and may contribute towards the detection of this lesion and our understanding of its pathogenetic and clinical implications in MM.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10397739

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  11 in total

Review 1.  The Role of Nuclear Receptor-Binding SET Domain Family Histone Lysine Methyltransferases in Cancer.

Authors:  Richard L Bennett; Alok Swaroop; Catalina Troche; Jonathan D Licht
Journal:  Cold Spring Harb Perspect Med       Date:  2017-06-01       Impact factor: 6.915

2.  Fluorescence in situ hybridization analysis of immunoglobulin heavy chain translocations in plasma cell myeloma using intact paraffin sections and simultaneous CD138 immunofluorescence.

Authors:  James R Cook; Marybeth Hartke; James Pettay; Raymond R Tubbs
Journal:  J Mol Diagn       Date:  2006-09       Impact factor: 5.568

3.  Immunohistochemical analysis of cyclin D1 shows deregulated expression in multiple myeloma with the t(11;14).

Authors:  G Pruneri; S Fabris; L Baldini; N Carboni; S Zagano; M A Colombi; G Ciceri; L Lombardi; M Rocchi; R Buffa; A T Maiolo; A Neri
Journal:  Am J Pathol       Date:  2000-05       Impact factor: 4.307

4.  Translocation T(4;14)(p16.3;q32) is a recurrent genetic lesion in primary amyloidosis.

Authors:  V Perfetti; A M Coluccia; D Intini; U Malgeri; M C Vignarelli; S Casarini; G Merlini; A Neri
Journal:  Am J Pathol       Date:  2001-05       Impact factor: 4.307

5.  Microfluidic chips for detecting the t(4;14) translocation and monitoring disease during treatment using reverse transcriptase-polymerase chain reaction analysis of IgH-MMSET hybrid transcripts.

Authors:  Jaron VanDijken; Govind V Kaigala; Jana Lauzon; Alexey Atrazhev; Sophia Adamia; Brian J Taylor; Tony Reiman; Andrew R Belch; Christopher J Backhouse; Linda M Pilarski
Journal:  J Mol Diagn       Date:  2007-07       Impact factor: 5.568

Review 6.  Molecular aspects of multiple myeloma.

Authors:  G Pratt
Journal:  Mol Pathol       Date:  2002-10

7.  TACC3 is essential for EGF-mediated EMT in cervical cancer.

Authors:  Geun-Hyoung Ha; Jung-Lye Kim; Eun-Kyoung Breuer; Eun-Kyoung Yim Breuer
Journal:  PLoS One       Date:  2013-08-01       Impact factor: 3.240

8.  A chromatin scaffold for DNA damage recognition: how histone methyltransferases prime nucleosomes for repair of ultraviolet light-induced lesions.

Authors:  Corina Gsell; Holger Richly; Frédéric Coin; Hanspeter Naegeli
Journal:  Nucleic Acids Res       Date:  2020-02-28       Impact factor: 16.971

9.  Expressed fusion gene landscape and its impact in multiple myeloma.

Authors:  A Cleynen; R Szalat; M Kemal Samur; S Robiou du Pont; L Buisson; E Boyle; M L Chretien; K Anderson; S Minvielle; P Moreau; M Attal; G Parmigiani; J Corre; N Munshi; H Avet-Loiseau
Journal:  Nat Commun       Date:  2017-12-01       Impact factor: 14.919

10.  FGFR3 mRNA overexpression defines a subset of oligometastatic colorectal cancers with worse prognosis.

Authors:  Julia Elisabeth Fromme; Katja Schmitz; Astrid Wachter; Marius Grzelinski; Dirk Zielinski; Christina Koppel; Lena-Christin Conradi; Kia Homayounfar; Tabea Hugo; Sara Hugo; Laura Lukat; Josef Rüschoff; Philipp Ströbel; Michael Ghadimi; Tim Beißbarth; Kirsten Reuter-Jessen; Annalen Bleckmann; Hans-Ulrich Schildhaus
Journal:  Oncotarget       Date:  2018-08-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.